China Meheco Group Co Ltd operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Meheco Group Co Ltd with three other
companies in this sector in China:
Huadong Medicine Company Limited
sales of 27.83 billion Chinese Renmimbi [US$4.11 billion]
of which 78%
China National Medicines Corp., Ltd.
(36.28 billion Chinese Renmimbi [US$5.36 billion]
of which 98%
was business department), and
Yunnan Baiyao Group Co., Ltd.
(24.31 billion Chinese Renmimbi [US$3.59 billion]
of which 59%
was Comodities Trading).
During the year ended December of 2017, sales at
China Meheco Group Co Ltd were 30.10 billion Chinese Renmimbi (US$4.45 billion).
increase of 17.0%
versus 2016, when the company's sales were 25.74 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at China Meheco Group Co Ltd
(and since 2012, sales have increased a total of 204%).
Sales of Pharmaceutical Manufacturing saw an increase
that was more than double the company's growth rate: sales were up
54.7% in 2017, from
2.43 billion Chinese Renmimbi to 3.75 billion Chinese Renmimbi.